Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.

CONCLUSIONS: Our findings suggested that serum miR-100 might serve as promising biomarker for GBM diagnosis and prognosis.
PMID: 30530966 [PubMed - as supplied by publisher]

Source: Cancer Biomarkers : Section A of Disease Markers - November 26, 2018 Category: Cancer & Oncology Authors: Zhang H, Wang J, Wang Z, Ruan C, Wang L, Guo H Tags: Cancer Biomark Source Type: research